Literature DB >> 11563629

Non-expanded polyglutamine proteins in intranuclear inclusions of hereditary ataxias--triple-labeling immunofluorescence study.

T Uchihara1, H Fujigasaki, S Koyano, A Nakamura, S Yagishita, K Iwabuchi.   

Abstract

Neuronal intranuclear inclusions (NIIs) found in CAG/polyglutamine-expansion disorders contain both expanded polyglutamine and the gene product without the CAG repeat. The gene product containing expanded polyglutamine has, therefore, been considered to be a major component of NIIs. In this immunohistochemical study, we showed recruitment of ataxin-2, ataxin-3 and TATA box binding protein (TBP) into NIIs of the pontine neurons of spinocerebellar ataxia type (SCA) 1, SCA2, SCA3 and dentatorubral-pallidoluysian atrophy brains. Triple-labeling immunofluorescence demonstrated colocalization of ataxin-2 and ataxin-3 in NIIs containing expanded polyglutamine, irrespective of the disease examined. These in vivo findings indicate that polyglutamine proteins recruited into NIIs are not restricted to their expanded form. Among these proteins, recruitment of ataxin-2 was least frequent in every case examined, suggesting that the rate of recruitment partly depends on the protein transported into NIIs. Because other proteins lacking polyglutamine motif were not detected in NIIs, it is suggested that the presence of polyglutamine is a prerequisite for these proteins to be recruited into nucleus and to form NIIs. Interaction between expanded and non-expanded polyglutamine may play roles during these processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11563629     DOI: 10.1007/s004010100364

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

Review 1.  Aggresome formation and neurodegenerative diseases: therapeutic implications.

Authors:  J A Olzmann; L Li; L S Chin
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

2.  Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells.

Authors:  Andreia Neves-Carvalho; Elsa Logarinho; Ana Freitas; Sara Duarte-Silva; Maria do Carmo Costa; Anabela Silva-Fernandes; Margarida Martins; Sofia Cravino Serra; André T Lopes; Henry L Paulson; Peter Heutink; João B Relvas; Patrícia Maciel
Journal:  Hum Mol Genet       Date:  2014-08-20       Impact factor: 6.150

3.  Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.

Authors:  Philipp Koch; Peter Breuer; Michael Peitz; Johannes Jungverdorben; Jaideep Kesavan; Daniel Poppe; Jonas Doerr; Julia Ladewig; Jerome Mertens; Thomas Tüting; Per Hoffmann; Thomas Klockgether; Bernd O Evert; Ullrich Wüllner; Oliver Brüstle
Journal:  Nature       Date:  2011-11-23       Impact factor: 49.962

4.  A Drosophila model of the neurodegenerative disease SCA17 reveals a role of RBP-J/Su(H) in modulating the pathological outcome.

Authors:  Jie Ren; Anil G Jegga; Minlu Zhang; Jingyuan Deng; Junbo Liu; Christopher B Gordon; Bruce J Aronow; Long J Lu; Bo Zhang; Jun Ma
Journal:  Hum Mol Genet       Date:  2011-06-08       Impact factor: 6.150

Review 5.  Spinocerebellar ataxia type 2: clinical presentation, molecular mechanisms, and therapeutic perspectives.

Authors:  J J Magaña; L Velázquez-Pérez; B Cisneros
Journal:  Mol Neurobiol       Date:  2012-09-21       Impact factor: 5.590

6.  Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates.

Authors:  Kathryn M Donaldson; Wei Li; Keith A Ching; Serge Batalov; Chih-Cheng Tsai; Claudio A P Joazeiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-11       Impact factor: 11.205

7.  The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains.

Authors:  Brett J Winborn; Sue M Travis; Sokol V Todi; K Matthew Scaglione; Ping Xu; Aislinn J Williams; Robert E Cohen; Junmin Peng; Henry L Paulson
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

Review 8.  Spinocerebellar ataxia 2 (SCA2).

Authors:  Isabel Lastres-Becker; Udo Rüb; Georg Auburger
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  Spinocerebellar ataxia 17 (SCA17) and Huntington's disease-like 4 (HDL4).

Authors:  Giovanni Stevanin; Alexis Brice
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

10.  Ataxin-2 mediated cell death is dependent on domains downstream of the polyQ repeat.

Authors:  Hiushan Ng; Stefan-M Pulst; Duong P Huynh
Journal:  Exp Neurol       Date:  2007-08-28       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.